Inflammatory Breast Cancer: Still a Diagnostic Dilemma
Journal of Surgery
Volume 2, Issue 3, June 2014, Pages: 42-45
Received: Mar. 4, 2014; Accepted: May 26, 2014; Published: Jun. 10, 2014
Views 3027      Downloads 88
Authors
W. M. Isichei, Department of Surgery, Jos University Teaching Hospital Jos, Plateau state Nigeria
M. A. Misauno, Department of Surgery, Jos University Teaching Hospital Jos, Plateau state Nigeria
Article Tools
Follow on us
Abstract
Background: Inflammatory breast cancer (IBC) is a rapidly progressive disease associated with high mortality in developing countries. The patients are managed for mastitis’s first and IBC becomes a diagnosis of exclusion after failed response to appropriate antibiotic therapy. This study was aimed at evaluating the outcome of management of IBC in North central Nigeria. Patients and method: This was a prospective analysis of consecutive patients presenting with breast cancer at the Abubakar Tafawa Balewa University teaching hospital Bauchi (ATBUTH) from January 2011 to December 2012. Results: A total of 52 breast cancers were managed, mean age was 31+/- 2years with an age range of 29 -33 years. There were 51 females and 1male (f: m = 51:1). IBC accounted for 9(17.3 %) of the breast cancers. Conclusion: IBC is frequently misdiagnosed as mastitis for various reasons and a high index of suspicion is required to clinch the diagnosis.
Keywords
Inflammatory, Breast, Cancer, Mastitis, Misdiagnosis
To cite this article
W. M. Isichei, M. A. Misauno, Inflammatory Breast Cancer: Still a Diagnostic Dilemma, Journal of Surgery. Vol. 2, No. 3, 2014, pp. 42-45. doi: 10.11648/j.js.20140203.12
References
[1]
Schlichting, J. A.;Soliman, A. S. ;Schairer, C.;Schottenfeld, D.;Merajver, S. Inflammatory and non-inflammatory breast cancer survival by socioeconomic position in the Surveillance, Epidemiology, and End Results database, 1990-2008.Department of Epidemiology, University of Michigan School of Public Health, 109 Observatory St., Ann Arbor, MI 48109-2029, USA. jschlic@umich.edu
[2]
Waller KP. Mammary gland immunology around parturition. Influence of stress, nutrition and genetics. Adv Exp Med Biol. 2000;480:231-45.
[3]
Tabbane F, el May A, Hachiche M, Bahi J, Jaziri M, Cammoun M, et al. Breast cancer in women under 30 years of age. Breast Cancer Res Treat. 1985;6(2):137-44.
[4]
Dahl beck SW, Donnelly JF, Theriault RL. Differentiating inflammatory breast cancer from acute mastitis. The Family physician 1995 Sep 1; 52(3):929-34. University of Minnesota Hospital and Clinic, Minneapolis, USA.
[5]
Alunni JP. Imaging inflammatory breast cancer. Diagn Interv Imaging. 2012 Feb;93(2):95-103.
[6]
Uematsu T. MRI findings of inflammatory breast cancer, locally advanced breast cancer, and acute mastitis: T2-weighted images can increase the specificity of inflammatory breast cancer,2012 Oct;19(4):289-94. doi: 10.1007/s12282-012-0346-1. Epub 2012 Feb 21.Breast Imaging and Breast Intervention Section, Shizuoka Cancer Center Hospital, Naga-izumi, Shizuoka, 411-8777, Japan. t.uematsu@scchr.j
[7]
Anne N, Pallapothu R. Lymphoma of the breast: a mimic of inflammatory breast cancer. World J Surg Oncol. 2011;9:125.
[8]
Alvarez RH, Gong Y, Ueno NT, Alizadeh PA, Hortobagyi GN, Valero V. Metastasis in the breast mimicking inflammatory breast cancer. J Clin Oncol. 2012 Aug 1;30(22):e202-6.
[9]
Li BD, Sicard MA, Ampil F, Abreo F, Lilien D, Chu QD, Burton GV. Trimodal therapy for inflammatory breast cancer: a surgeon's perspective 2010;79(1-2):3-12. doi: 10.1159/000318529. Epub 2010 Nov 3. Department of Surgery, Radiology, Pathology and Medicine, Louisiana State University Health Sciences Center in Shreveport, and Feist-Weiller Cancer Center, Shreveport, La 71130, USA. bli@lsuhsc.edu
[10]
Boussen H, Bouzaiene H, Ben Hassouna J, Dhiab T, Khomsi F, Benna F, et al. Inflammatory breast cancer in Tunisia: epidemiological and clinical trends. Cancer. 2010 Jun 1;116(11 Suppl):2730-5.
[11]
Meyer KK. Diagnostic error in breast disease. Am Surg. 1975 Dec;41(12):774-85.
[12]
Robertson FM, Bondy M, Yang W, Yamauchi H, Wiggins S, Kamrudin S, Krishnamurthy S, Le-Petross H, Bidaut L, Player AN, Barsky SH, Woodward WA, Buchholz T, Lucci A, Ueno NT, Cristofanilli M. Inflammatory breast cancer: the disease, the biology, the treatment. C A Cancer J Clin. 2010 Nov-Dec;60(6):351-75. doi: 10.3322/caac.20082. Epub 2010 Oct Department of Experimental Therapeutics, the University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.CA Cancer J Clin. 2011 Mar-Apr; 61(2):134. Ueno, Naoto [corrected to Ueno, Naoto T].
[13]
Abrous-Anane S, Savignoni A, Daveau C, Pierga JY, Gautier C, Reyal F, et al. [Management of inflammatory breast cancer after neo-adjuvant chemotherapy]. Cancer Radiother. 2011 Dec;15(8):654-62.
[14]
Abdulrahman GO, Jr., Rahman GA. Epidemiology of breast cancer in europe and Africa. J Cancer Epidemiol. 2012;2012:915610.
[15]
Shah NM, Soliman AS, Benerjee M, Merajver SD, Ismail K, Seifeldin I, et al. Knowledge gained after a brief CME module on breast cancer diagnosis. J Cancer Educ. 2006 Fall; 21(3):169-74.
[16]
Dauda AM, Misauno MA, Ojo EO. Histopathological types of breast cancer in Gombe, North Eastern Nigeria: a seven-year review. Afr J Reprod Health. 2011 Mar;15(1):109-11.
[17]
Lo AC, Kleer CG, Banerjee M, Omar S, Khaled H, Eissa S, et al. Molecular epidemiologic features of inflammatory breast cancer: a comparison between Egyptian and US patients. Breast Cancer Res Treat. 2008 Nov;112(1):141-7.
[18]
Lo AC, Kleer CG, Banerjee M, Omar S, Khaled H, Eissa S, et al. Molecular epidemiologic features of inflammatory breast cancer: a comparison between Egyptian and US patients. Breast Cancer Res Treat. 2008 Nov;112(1):141-7.
[19]
Labidi SI, Mrad K, Mezlini A, Ouarda MA, Combes JD, Ben Abdallah M, et al. In-flammatory breast cancer in Tunisia in the era of multimodality therapy. Ann Oncol. 2008 Mar;19(3):473-80.
ADDRESS
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
U.S.A.
Tel: (001)347-983-5186